EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine

Lucia Cannella iD, Rosa Della Monica, Antonella Lucia Marretta, Domenico Iervolino iD, Bruno Vincenzi, Anna Rosaria De Chiara, Ottavia Clemente iD, Michela Buonaiuto, Maria Luisa Barretta, Annabella Di Mauro, Massimiliano Di Marzo, Michele Guida und 3 weitere

Cells · 2023

DOI: 10.3390/cells12121635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Lucia Cannella und 14 weiteren Autor:innen. Beteiligte Einrichtung: S.C. Sarcomi e Tumori Rari, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy. Hauptthemen laut MEDLINE: Brain Neoplasms, Leiomyosarcoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dacarbazine is an important drug in the therapeutic landscape of leiomyosarcoma (LMS). Alkylating agents are subjected to resistance mechanisms based on anti-apoptotic pathways and repair mechanisms, including the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT). In this retrospective study, the methylation status of the MGMT promoter in histological tumor samples from patients with LMS, dacarbazine-based regimens-treated, was measured and correlated with clinical outcomes aimed at optimizing the use of dacarbazine in soft tissue sarcomas. The patients with unmethylated MGMT had better outcomes than those with methylated MGMT. Patients without MGMT methylation had better Progression Free Survival (PFS) when aged ≥62 years compared to those aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsLeiomyosarcomaHumansAntineoplastic Agents, AlkylatingDacarbazineDNADNA MethylationDNA Modification MethylasesDNA Repair EnzymesMethyltransferasesRetrospective StudiesTemozolomideTumor Suppressor ProteinsMiddle AgedGuanine

Stichwörter der Autor:innen

MGMTO6-methylguanine-DNA methyltransferasedacarbazineleiomyosarcomasoft-tissue tumor

Substanzen

Antineoplastic Agents, AlkylatingDacarbazineDNADNA Modification MethylasesDNA Repair EnzymesMethyltransferasesTemozolomideTumor Suppressor ProteinsMGMT protein, humanO-(6)-methylguanine

Autor:innen und Institutionen

  • S.C. Sarcomi e Tumori Rari, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy.
  • CEINGE-Biotecnologie Avanzate, 80131 Naples, Italy.
  • Department of Clinical and Surgery Oncology Unit, University of Naples "Federico II", 80131 Naples, Italy.
  • S.C. Anatomia Patologica, IsIstituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy.
  • Dipartimento di Oncologia Medica, Campus Bio-Medico University, 00168 Rome, Italy.
  • S.S.D Istopatologia dei Linfomi e dei Sarcomi, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy.

ORCID-Profile: Lucia Cannella, Domenico Iervolino, Ottavia Clemente, Giuseppe Badalamenti, Salvatore Tafuto

Förderung

  • Italian Ministry of Health

Zitieren

APA

Cannella, L., Della Monica, R., Marretta, A. L., Iervolino, D., Vincenzi, B., De Chiara, A. R., Clemente, O., Buonaiuto, M., Barretta, M. L., Di Mauro, A., Di Marzo, M., Guida, M., Badalamenti, G., Chiariotti, L., & Tafuto, S. (2023). The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine. Cells. https://doi.org/10.3390/cells12121635

Vancouver

Cannella L, Della Monica R, Marretta AL, Iervolino D, Vincenzi B, De Chiara AR, et al. The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine. Cells. 2023. doi:10.3390/cells12121635

BibTeX
@article{Cannella2023,
  author = {Cannella, Lucia and Della Monica, Rosa and Marretta, Antonella Lucia and Iervolino, Domenico and Vincenzi, Bruno and De Chiara, Anna Rosaria and Clemente, Ottavia and Buonaiuto, Michela and Barretta, Maria Luisa and Di Mauro, Annabella and Di Marzo, Massimiliano and Guida, Michele and Badalamenti, Giuseppe and Chiariotti, Lorenzo and Tafuto, Salvatore},
  title = {The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12121635}
}
Kostenlos starten →